India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials
Tuesday, 30 June 2020 () Hyderabad-based Bharat Biotech has developed a potential vaccine to combat the Covid-19 disease. The vaccine is named Covaxin and represents India’s effort in curbing down the spread of Coronavirus that has ravaged countries across the globe. Covaxin contains a weakened version of the SARS-CoV-2 virus (Coronavirus) which will be injected into the patient’s body to […]
The post India’s 1st COVID-19 Vaccine Candidate “Covaxin” Approved For Human Trials appeared first on Fossbytes.
India's Covaxin has entered clinical trials while the Drug controller Genral of India gave the nod for another vaccine by Zydus Cadila for phase I and II human trials. ICMR has asked Bharat Biotech to fast-track vaccine trials keeping a roll-out date of August 15th in mind. With 2 vaccines in the...